Renal cell carcinoma bone metastasis—elucidating the molecular targets
Authors:
- 2 September 2007
- journal article
- review article
- Published by Springer Nature in Cancer and Metastasis Reviews
- Vol. 26 (3-4) , 691-704
Abstract
The development of bone metastasis from renal cell carcinoma (RCC) signals a transition to a terminal state for the patient with previously isolated disease. These patients may suffer the morbidity of severe, persistent pain, pathologic fractures, and spinal compression from vertebral metastasis before they succumb to their cancer. Although recent advancements have been made in the understanding of breast and prostate bone metastasis, there has been less knowledge in the area of metastatic RCC to the skeleton. This particular cancer in bone remains relatively resistant to standard forms of treatment such as radiation and chemotherapy. A better understanding of the biology of RCC bone metastasis is critically needed in order to improve treatment. Bone-derived cell lines and an experimental animal model have been developed in order to explore the relevant mechanisms of how RCC cells survive within and destroy the bone. This review will focus on the growth factor signaling pathways most important for the RCC-stimulated osteoclast-mediated bone destruction, namely the epidermal growth factor receptor (EGF-R) and transforming growth factor-β receptor (TGF-βR) pathways. By inhibiting these receptors, growth of RCC within the bone is decreased which, directly or indirectly, decreases bone destruction.Keywords
This publication has 44 references indexed in Scilit:
- TGF-β Promotes the Establishment of Renal Cell Carcinoma Bone MetastasisJournal of Bone and Mineral Research, 2007
- Development of TGF-β signalling inhibitors for cancer therapyNature Reviews Drug Discovery, 2004
- Gemcitabine and oxaliplatin in the treatment of patients with immunotherapy‐resistant advanced renal cell carcinomaCancer, 2004
- Transforming Growth Factor-β1 Regulation of Collagenase-3 Expression in Osteoblastic Cells by Cross-talk between the Smad and MAPK Signaling Pathways and Their Components, Smad2 and Runx2Journal of Biological Chemistry, 2004
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- TGF-β signaling: positive and negative effects on tumorigenesisCurrent Opinion in Genetics & Development, 2002
- Effects of EGF and TGF-α on Invasion and Proteinase Expression of Uterine Cervical Adenocarcinoma OMC-4 CellsInvasion and Metastasis, 1998
- Role of cytokines in the regulation of bone resorptionCalcified Tissue International, 1993
- Interleukin‐6 (IL‐6) functions as an in vitro autocrine growth factor in renal cell carcinomasFEBS Letters, 1989